Startups
ATUM, formerly DNA2.0, offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and production. ATUM exploits the dependence of biological activity on well-designed sequences. ATUM’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. By collaborating with our clients, ATUM accelerates breakthroughs and moves research further faster.
Overview
Location
United States, California, Newark
Employees
51-200
Founded date
2003
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 18, 2024 | Reimagining the Translation from Biologics Discovery to Development, Upcoming Webinar Hosted by Xtalks | www.atum.bio In this free webinar, gain insights into the most effective tools, technologies and strategies for biologics discovery and development. Attendees will learn about stable bulk cultures (SBC)-based platforms, which represent a pa... |
| Jul 26, 2023 | Utilizing AI to Engineer Biologics: From Discovery to Manufacturing, Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars The webinar is particularly well suited for professionals in the fields of protein engineering, biomedical engineering, drug discovery, bioinformatics, computational biology, pharmaceutical and biotechnology man... |
Reviews 0
FAQ about ATUM
When was ATUM founded?
ATUM was founded in 2003.
What has the press written about ATUM?
Parsers VC has collected 3 articles mentioning ATUM, among them “Reimagining the Translation from Biologics Discovery to Development, Upcoming Webinar Hosted by Xtalks” (Apr 18, 2024) and “Utilizing AI to Engineer Biologics: From Discovery to Manufacturing, Upcoming Webinar Hosted by Xtalks” (Jul 26, 2023).
Is ATUM still active?
Yes, ATUM is active; its latest activity on Parsers VC dates from Aug 14, 2024.